US Stock MarketDetailed Quotes

IKT Inhibikase Therapeutics

Watchlist
  • 2.1600
  • -0.1400-6.09%
Close Mar 28 16:00 ET
  • 2.1200
  • -0.0400-1.85%
Post 19:43 ET
13.99MMarket Cap-605P/E (TTM)

Inhibikase Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.43%-4.11M
-4.81%-4.57M
-51.80%-5.97M
-21.36%-17.35M
13.17%-3.56M
-172.44%-5.5M
-2.57%-4.36M
0.00%-3.93M
-1,165.95%-14.3M
-332.72%-4.1M
Net income from continuing operations
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-419.19%-14.79M
-317.36%-5.04M
Operating gains losses
----
----
----
----
----
----
----
----
-52.28%688.78K
-96.78%29.84K
Depreciation and amortization
291.61%6.58K
--159.2K
--5.04K
--6.72K
--5.04K
--1.68K
--0
--0
--0
--0
Other non cash items
----
----
----
104.01%67K
---20.82K
--20.82K
--0
104.01%67K
-80.22%32.84K
--0
Change In working capital
129.66%336.46K
513.42%928.53K
-414.36%-1.62M
109.70%171.18K
-1.85%638.09K
-159.19%-1.13M
106.97%151.37K
123.91%516.18K
-279.76%-1.76M
174.47%650.11K
-Change in receivables
1,191.93%79.6K
-136.41%-15.08K
-139.63%-24.64K
163.79%70.26K
-124.26%-26.04K
-101.98%-7.29K
116.32%41.42K
118.68%62.17K
---110.14K
--107.34K
-Change in prepaid assets
-14.42%250.05K
541,297.53%876.74K
-368.16%-564.82K
142.11%328.66K
119.56%157.28K
-70.40%292.19K
99.99%-162
-146.00%-120.65K
-1,958.75%-780.53K
-1,854.62%-803.96K
-Change in payables and accrued expense
100.54%7.7K
-21.58%67.77K
-279.64%-1.03M
-117.63%-255.93K
-62.70%502.34K
-301.88%-1.42M
-79.23%86.42K
156.67%574.66K
209.68%1.45M
212.31%1.35M
-Change in other current assets
----
----
--25.38K
----
----
----
----
--0
----
----
-Change in other current liabilities
---27.89K
---27.07K
---26.28K
---9.86K
---9.86K
--0
--0
--0
----
----
-Change in other working capital
2,700,300.00%27K
----
----
101.64%38.06K
--14.37K
100.00%-1
----
----
-359.25%-2.33M
--0
Cash from discontinued investing activities
Operating cash flow
25.43%-4.11M
-4.81%-4.57M
-51.80%-5.97M
-21.36%-17.35M
13.17%-3.56M
-172.44%-5.5M
-2.57%-4.36M
0.00%-3.93M
-1,165.95%-14.3M
-332.72%-4.1M
Investing cash flow
Cash flow from continuing investing activities
181.53%17.06M
6,017.70%2.55M
-5.84M
-16.01M
4.96M
-20.93M
-43.09K
0
0
0
Net PPE purchase and sale
--0
----
----
---243.26K
--0
---200.17K
----
----
--0
--0
Net investment purchase and sale
182.32%17.06M
--2.56M
---5.84M
---15.76M
--4.96M
---20.73M
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
181.53%17.06M
6,017.70%2.55M
---5.84M
---16.01M
--4.96M
---20.93M
---43.09K
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
70
-35.99K
4,289.61%8.58M
-100.50%-204.77K
0
0
0
50.02%-204.77K
172.79%41.09M
0
Net issuance payments of debt
--0
--0
--0
-485.20%-248.91K
--0
--0
--0
39.24%-248.91K
-115.59%-42.53K
--0
Net common stock issuance
--70
---35.99K
--8.58M
--0
--0
--0
--0
--0
178.10%41.14M
--0
Proceeds from stock option exercised by employees
--0
--0
--0
-43.77%44.14K
--0
--0
--0
--44.14K
--78.5K
--0
Net other financing activities
----
----
----
----
----
----
----
----
---77.65K
--0
Cash from discontinued financing activities
Financing cash flow
--70
---35.99K
4,289.61%8.58M
-100.50%-204.77K
--0
--0
--0
50.02%-204.77K
172.79%41.09M
--0
Net cash flow
Beginning cash position
-94.09%1.91M
-89.19%3.96M
-82.36%7.19M
192.04%40.75M
-87.11%5.78M
-31.22%32.21M
280.98%36.61M
192.04%40.75M
75,500.11%13.95M
277,274.75%44.85M
Current changes in cash
149.02%12.96M
53.36%-2.05M
21.91%-3.23M
-225.25%-33.56M
134.34%1.41M
-1,227.75%-26.43M
-111.82%-4.4M
4.72%-4.14M
92.30%26.8M
-129.39%-4.1M
End cash Position
157.03%14.86M
-94.09%1.91M
-89.19%3.96M
-82.36%7.19M
-82.36%7.19M
-87.11%5.78M
-31.22%32.21M
280.98%36.61M
192.04%40.75M
192.04%40.75M
Free cash flow
28.04%-4.11M
-4.11%-4.58M
-51.80%-5.97M
-23.06%-17.59M
13.17%-3.56M
-182.35%-5.7M
-3.59%-4.4M
0.00%-3.93M
-1,165.95%-14.3M
-332.72%-4.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.43%-4.11M-4.81%-4.57M-51.80%-5.97M-21.36%-17.35M13.17%-3.56M-172.44%-5.5M-2.57%-4.36M0.00%-3.93M-1,165.95%-14.3M-332.72%-4.1M
Net income from continuing operations -2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M-76.01%-4.64M-75.98%-4.64M-419.19%-14.79M-317.36%-5.04M
Operating gains losses ---------------------------------52.28%688.78K-96.78%29.84K
Depreciation and amortization 291.61%6.58K--159.2K--5.04K--6.72K--5.04K--1.68K--0--0--0--0
Other non cash items ------------104.01%67K---20.82K--20.82K--0104.01%67K-80.22%32.84K--0
Change In working capital 129.66%336.46K513.42%928.53K-414.36%-1.62M109.70%171.18K-1.85%638.09K-159.19%-1.13M106.97%151.37K123.91%516.18K-279.76%-1.76M174.47%650.11K
-Change in receivables 1,191.93%79.6K-136.41%-15.08K-139.63%-24.64K163.79%70.26K-124.26%-26.04K-101.98%-7.29K116.32%41.42K118.68%62.17K---110.14K--107.34K
-Change in prepaid assets -14.42%250.05K541,297.53%876.74K-368.16%-564.82K142.11%328.66K119.56%157.28K-70.40%292.19K99.99%-162-146.00%-120.65K-1,958.75%-780.53K-1,854.62%-803.96K
-Change in payables and accrued expense 100.54%7.7K-21.58%67.77K-279.64%-1.03M-117.63%-255.93K-62.70%502.34K-301.88%-1.42M-79.23%86.42K156.67%574.66K209.68%1.45M212.31%1.35M
-Change in other current assets ----------25.38K------------------0--------
-Change in other current liabilities ---27.89K---27.07K---26.28K---9.86K---9.86K--0--0--0--------
-Change in other working capital 2,700,300.00%27K--------101.64%38.06K--14.37K100.00%-1---------359.25%-2.33M--0
Cash from discontinued investing activities
Operating cash flow 25.43%-4.11M-4.81%-4.57M-51.80%-5.97M-21.36%-17.35M13.17%-3.56M-172.44%-5.5M-2.57%-4.36M0.00%-3.93M-1,165.95%-14.3M-332.72%-4.1M
Investing cash flow
Cash flow from continuing investing activities 181.53%17.06M6,017.70%2.55M-5.84M-16.01M4.96M-20.93M-43.09K000
Net PPE purchase and sale --0-----------243.26K--0---200.17K----------0--0
Net investment purchase and sale 182.32%17.06M--2.56M---5.84M---15.76M--4.96M---20.73M--0--0--0--0
Cash from discontinued investing activities
Investing cash flow 181.53%17.06M6,017.70%2.55M---5.84M---16.01M--4.96M---20.93M---43.09K--0--0--0
Financing cash flow
Cash flow from continuing financing activities 70-35.99K4,289.61%8.58M-100.50%-204.77K00050.02%-204.77K172.79%41.09M0
Net issuance payments of debt --0--0--0-485.20%-248.91K--0--0--039.24%-248.91K-115.59%-42.53K--0
Net common stock issuance --70---35.99K--8.58M--0--0--0--0--0178.10%41.14M--0
Proceeds from stock option exercised by employees --0--0--0-43.77%44.14K--0--0--0--44.14K--78.5K--0
Net other financing activities -----------------------------------77.65K--0
Cash from discontinued financing activities
Financing cash flow --70---35.99K4,289.61%8.58M-100.50%-204.77K--0--0--050.02%-204.77K172.79%41.09M--0
Net cash flow
Beginning cash position -94.09%1.91M-89.19%3.96M-82.36%7.19M192.04%40.75M-87.11%5.78M-31.22%32.21M280.98%36.61M192.04%40.75M75,500.11%13.95M277,274.75%44.85M
Current changes in cash 149.02%12.96M53.36%-2.05M21.91%-3.23M-225.25%-33.56M134.34%1.41M-1,227.75%-26.43M-111.82%-4.4M4.72%-4.14M92.30%26.8M-129.39%-4.1M
End cash Position 157.03%14.86M-94.09%1.91M-89.19%3.96M-82.36%7.19M-82.36%7.19M-87.11%5.78M-31.22%32.21M280.98%36.61M192.04%40.75M192.04%40.75M
Free cash flow 28.04%-4.11M-4.11%-4.58M-51.80%-5.97M-23.06%-17.59M13.17%-3.56M-182.35%-5.7M-3.59%-4.4M0.00%-3.93M-1,165.95%-14.3M-332.72%-4.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg